Clinical and laboratory findings of ITP-onset APS (group A) patients
| No. . | Age, y . | G . | IPC, × 109 . | LA . | ACA IgG . | ACA IgM . | APS clinical findings . | TFE . |
|---|---|---|---|---|---|---|---|---|
| 1 | 53 | F | 12 | (−) | 63 | 36 | DVT | 12 |
| 2 | 38 | M | 110 | (+) | 14.9 | 4.7 | RVT | 12 |
| 3 | 37 | F | 47 | (+) | 26 | 6.9 | FL and SLE | 71 |
| 4 | 24 | M | 90 | (+) | 100 | 25 | DVT + PE | 38 |
| 5 | 36 | F | 50 | (+) | 2.6 | 1.6 | Stroke | 5 |
| 6 | 42 | F | 30 | (+) | 13.9 | 3.9 | FL, MesO | 60 |
| 7 | 46 | F | 15 | (+) | 7.1 | 5.5 | DVT + PE | 49 |
| 8 | 44 | F | 90 | (+) | NA | NA | Stroke | 13 |
| 9 | 27 | F | 22 | (+) | 86.7 | 7.2 | FL | 21 |
| 10 | 32 | F | 20 | (+) | 1.0 | 2.0 | Stroke | 38 |
| 11 | 42 | F | 30 | (+) | 5.9 | 4.6 | FL, SLE | 72 |
| 12 | 20 | F | 62 | (+) | NA | NA | DVT, SLE | 39 |
| 13 | 30 | F | 30 | (+) | 2.0 | 3.2 | DVT | 40 |
| 14 | 38 | F | 40 | (+) | 44 | 5.2 | Stroke and FL | 12 |
| No. . | Age, y . | G . | IPC, × 109 . | LA . | ACA IgG . | ACA IgM . | APS clinical findings . | TFE . |
|---|---|---|---|---|---|---|---|---|
| 1 | 53 | F | 12 | (−) | 63 | 36 | DVT | 12 |
| 2 | 38 | M | 110 | (+) | 14.9 | 4.7 | RVT | 12 |
| 3 | 37 | F | 47 | (+) | 26 | 6.9 | FL and SLE | 71 |
| 4 | 24 | M | 90 | (+) | 100 | 25 | DVT + PE | 38 |
| 5 | 36 | F | 50 | (+) | 2.6 | 1.6 | Stroke | 5 |
| 6 | 42 | F | 30 | (+) | 13.9 | 3.9 | FL, MesO | 60 |
| 7 | 46 | F | 15 | (+) | 7.1 | 5.5 | DVT + PE | 49 |
| 8 | 44 | F | 90 | (+) | NA | NA | Stroke | 13 |
| 9 | 27 | F | 22 | (+) | 86.7 | 7.2 | FL | 21 |
| 10 | 32 | F | 20 | (+) | 1.0 | 2.0 | Stroke | 38 |
| 11 | 42 | F | 30 | (+) | 5.9 | 4.6 | FL, SLE | 72 |
| 12 | 20 | F | 62 | (+) | NA | NA | DVT, SLE | 39 |
| 13 | 30 | F | 30 | (+) | 2.0 | 3.2 | DVT | 40 |
| 14 | 38 | F | 40 | (+) | 44 | 5.2 | Stroke and FL | 12 |
G indicates gender; IPC, initial platelet count; TFE, timing of first APS event (the time between ITP diagnosis and occurrence of the first thrombotic or obstetric event); DVT, deep vein thrombosis; RVT, retinal vein thrombosis; FL, fetal loss; SLE, systemic lupus erythematosus; PE, pulmonary embolism; MesO, mesenteric artery occlusion; NA, not available.